Quick Answer
Altimmune, Inc. reported Total Assets of $279.93 million for the year ending 2025.
- Altimmune, Inc. showed an increase of +100.9% in Total Assets from 2024 to 2025.
- This data is from Altimmune, Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $26.32 million | Q3 2011: $21.64 million | Q1 2012: $24.75 million | Q2 2012: $23.81 million | Q3 2012: $23.41 million | Q1 2013: $21.97 million | Q2 2013: $24.59 million | Q3 2013: $20.62 million | Q1 2014: $14.37 million | Q2 2014: $15.22 million | Q3 2014: $23.35 million | Q1 2015: $25.47 million | Q2 2015: $22.62 million | Q3 2015: $20.90 million | Q1 2016: $18.73 million | Q2 2016: $27.93 million | Q3 2016: $140.54 million | Q1 2017: $20.73 million | Q2 2017: $90.84 million | Q3 2017: $74.35 million | Q1 2018: $60.87 million | Q2 2018: $52.10 million | Q3 2018: $52.86 million | Q1 2019: $65.37 million | Q2 2019: $61.98 million | Q3 2019: $56.39 million | Q1 2020: $54.23 million | Q2 2020: $102.54 million | Q3 2020: $233.00 million | Q1 2021: $264.25 million | Q2 2021: $257.26 million | Q3 2021: $236.91 million | Q1 2022: $205.66 million | Q2 2022: $209.91 million | Q3 2022: $225.28 million | Q1 2023: $187.08 million | Q2 2023: $183.32 million | Q3 2023: $166.57 million | Q1 2024: $188.36 million | Q2 2024: $173.35 million | Q3 2024: $147.86 million | Q1 2025: $157.26 million | Q2 2025: $190.35 million | Q3 2025: $218.45 million.
- Over the full 16 years of available data (2010 to 2025), Altimmune, Inc.'s Total Assets has grown by 929.2%.
- Historical annual values: Fiscal year 2025: $279.93 million | Fiscal year 2024: $139.31 million | Fiscal year 2023: $210.64 million | Fiscal year 2022: $206.93 million | Fiscal year 2021: $218.87 million | Fiscal year 2020: $245.12 million | Fiscal year 2019: $54.06 million | Fiscal year 2018: $54.75 million | Fiscal year 2017: $63.03 million | Fiscal year 2016: $38.40 million | Fiscal year 2015: $19.86 million | Fiscal year 2014: $21.98 million | Fiscal year 2013: $17.14 million | Fiscal year 2012: $22.74 million | Fiscal year 2011: $22.80 million | Fiscal year 2010: $27.20 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: